Water-soluble complexing agents and corresponding lanthanide complexes
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
C07D-255/02
C07F-009/32
C07D-473/18
C07F-009/58
C07F-009/6558
C07D-213/79
C07F-005/00
C07H-023/00
C09K-011/06
출원번호
US-0760912
(2014-01-16)
등록번호
US-9920082
(2018-03-20)
우선권정보
FR-13 50374 (2013-01-16)
국제출원번호
PCT/FR2014/050085
(2014-01-16)
국제공개번호
WO2014/111661
(2014-07-24)
발명자
/ 주소
Lamarque, Laurent
Parker, David
Butler, Stephen J.
Delbianco, Martina
출원인 / 주소
CISBO BIOASSAYS
대리인 / 주소
Hamre, Schumann, Mueller & Larson, P.C.
인용정보
피인용 횟수 :
0인용 특허 :
7
초록
The invention relates to complexing agents of formula (I): in which A, chrom1, chrom2 and chrom3 are as defined in the description. The invention also relates to the lanthanide complexes obtained from these complexing agents.
대표청구항▼
1. A complexing agent of formula (I′): wherein: A represents —CH2— or —CH(L2-G)-chrom1 and chrom2 are identical and represent a group of formula: chrom3 is either identical to chrom1 and chrom2, or is a group of formula: R2 and R2′, which may be identical or different, are selected from the group co
1. A complexing agent of formula (I′): wherein: A represents —CH2— or —CH(L2-G)-chrom1 and chrom2 are identical and represent a group of formula: chrom3 is either identical to chrom1 and chrom2, or is a group of formula: R2 and R2′, which may be identical or different, are selected from the group consisting of: H; -Alk; -phenyl; —CH2—CO—N-Alk; —CH2—CO—O-Alk; —CH2—CO—NH2; and —CH2—CO—OH;L1, L1′ and L2 are each independently selected from the group consisting of: a covalent bond; a linear or branched C1-C20 alkylene group optionally containing one or more double or triple bonds, said alkylene group being optionally substituted with up to 3 —SO3H groups; a C5-C8 cycloalkylene group; and a C6-C14 arylene group;wherein the alkylene group optionally contains one or more heteroatoms selected from the group consisting of O and N, or optionally contains one or more carbamoyl groups or one or more carboxamide groups; and wherein the alkylene group, the cycloalkylene group or the arylene group is optionally substituted with one or more groups selected from the group consisting of a C1-C8 alkyl group, a C6-C14 aryl group, a sulfonate group and an oxo group;E and E′, which may be identical or different, are groups increasing the water-solubility of the complexing agent, selected from the group consisting of: —SO3H, —PO(OH)2, —COOH, —N+Alk1Alk2Alk3, and a carbohydrate residue of formula —(CHOH)k—CH2OH wherein k is an integer from 3 to 12;R1 and R1′, which may be identical or different, are selected from the group consisting of: —COOH, and —PO(OH)R6, R6 being selected from the group consisting of: phenyl, benzyl, methyl, ethyl, propyl, n-butyl, sec-butyl, isobutyl, and tert-butyl;G is a reactive group selected from the group consisting of acrylamide, aldehyde, alkyl halide, anhydride, aniline, azide, aziridine, carboxylic acid, diazoalkane, haloacetamide, halotriazine, hydrazine, imido ester, isocyanate, isothiocyanate, maleimide, sulfonyl halide, thiol, ketone, amine, acid halide, succinimidyl ester, hydroxysuccinimidyl ester, hydroxysulfosuccinimidyl ester, azidonitrophenyl, azidophenyl, 3-(2-pyridyldithio)propionamide, glyoxal, triazine, and acetyl group;Alk, Alk1, Alk2 and Alk3, which may be identical or different, represent a (C1-C6)alkyl;provided that: when R1 or R1′ represents a —COOH group, E or E′ does not represent a —COOH group;the complexing agent comprises at least one group E or —SO3H;when chrom1, chrom2 and chrom3 each comprise a group R2 or R2′, A is a group —CH(L2-G)- in which L2 comprises at least one group —SO3H. 2. The complexing agent as claimed in claim 1, wherein A is the group —CH2— and chrom1, chrom2, chrom3 are identical and represent a group of formula: 3. The complexing agent as claimed in claim 1, wherein A is the group —CH2— and chrom3 is different from chrom1 and chrom2. 4. The complexing agent as claimed in claim 1, wherein A is the group —CH(L2-G)- and chrom1, chrom2 and chrom3 are identical. 5. The complexing agent as claimed in claim 1, wherein A is the group —CH(L2-G)- and chrom3 is different from chrom1 and chrom2. 6. The complexing agent as claimed in claim 1, wherein R1 and R1′ represent a group —PO(OH)CH3. 7. The complexing agent as claimed in claim 1, wherein E and E′ when they are present, represent a group —SO3H. 8. The complexing agent as claimed in claim 1, wherein R1 and R1′ represent a group —PO(OH)R6 and E and E′ represent a group —SO3H. 9. The complexing agent as claimed in claim 1, which comprises a group -L2-G. 10. The complexing agent as claimed in claim 1, wherein L1, L1′ and L2 are each independently a group selected from the group consisting of: in which n, m, p, q are integers from 1 to 16, and e is an integer in the range from 1 to 6. 11. The complexing agent as claimed in claim 1, wherein when the reactive group G is present, the reactive group G is selected from the group consisting of: in which w varies from 0 to 8 and v is equal to 0 or 1, and Ar is a saturated or unsaturated heterocycle with 5 or 6 ring members, comprising 1 to 3 heteroatoms, optionally substituted with a halogen atom. 12. The complexing agent as claimed in claim 1, wherein the group -L2-G consists of a reactive group G selected from the group consisting of: a carboxylic acid, an amine, a succinimidyl ester, a haloacetamide, a hydrazine, an isothiocyanate, a maleimide group, an aliphatic amine, and a spacer arm L2 consisting of an alkylene chain comprising 1 to 5 carbon atoms or a group selected from the group consisting of: where n, m are integers from 1 to 16, and e is an integer in the range from 1 to 6, the group G being bound to one or other end of these divalent groups. 13. The complexing agent as claimed in claim 1, wherein L1 or L1′, when they are present, each independently represent an alkylene chain comprising 1 to 5 carbon atoms or a group selected from the group consisting of: where n and m are integers from 1 to 16, and e is an integer in the range from 1 to 6, the group E or E′ being bound to one or other end of these divalent groups. 14. A lanthanide complex comprising a complexing agent as claimed in claim 1 and a lanthanide. 15. The lanthanide complex as claimed in claim 14, wherein the lanthanide is selected from the group consisting of: Eu3+, Tb3+, Gd3+, Dy3+, Nd3+, and Er3+. 16. A conjugate between (i) a molecule of interest comprising a functional group, said molecule being selected from the group consisting of: an amino acid, a protein, a carbohydrate chain, a nucleoside, a nucleotide, an oligonucleotide, an enzyme substrate, a chloroalkane and coenzyme A, and (ii) a lanthanide complex as claimed in claim 14, wherein said lanthanide complex comprises a group -L2-G, and wherein a covalent bond is formed between one or more atoms of group G and a functional group of the molecule of interest. 17. The complexing agent as claimed in claim 1, wherein A is the group —CH(L2-G)- and chrom1, chrom2 and chrom3 are identical. 18. The complexing agent as claimed in claim 1, wherein R1 and R1′ represent a group —PO(OH)CH3. 19. The complexing agent as claimed in claim 1, wherein E and E′ when they are present, represent a group —SO3H. 20. The complexing agent as claimed in claim 1, wherein R1 and R1′ represent a group —PO(OH)R6 and E and E′ represent a group —SO3H. 21. The complexing agent as claimed in claim 1, which comprises a group -L2-G. 22. The conjugate as claimed in claim 16, wherein the molecule of interest is a peptide, an antibody, or a sugar.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (7)
Selvin Paul R. (Berkeley CA) Hearst John (Berkeley CA), Luminescent lanthanide chelates and methods of use.
Mukkala Veli-Matti (Turku SEX) Sund Christian (Turku SEX) Kwiatkowski Marek (Uppsala SEX), Spectrofluorometric method and compounds that are of value for the method.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.